The Canadian COVID‑19 Funded Research Database

CHU de Québec

Algonquin College
Ambrose University
Association for Canadian Studies
Athabasca University
Aurora College

B.C. Centre for Disease Control
B.C. Centre for Excellence in HIV/AIDS
B.C. Children's Hospital
B.C. Women's Hospital
Bishop's University
Brandon University
British Columbia Centre on Substance Use
Brock University
Bruyère Research Institute

Dalhousie University
Dawson College
Durham College

École de technologie supérieure
École nationale d'administration publique
École Polytechnique de Montréal
Emily Carr University of Art and Design

Fanshawe College
First Nations Health Authority
Fleming College

Georgian College
Grant MacEwan University

HEC Montréal
Hospital for Sick Children
Humber College
Huron University College

Indigenous Diabetes Health Circle
INRS
Institut de recherches cliniques de Montréal
Institut de tourisme et d'hôtellerie du Québec
Institut national de la recherche scientifique
Institut national de santé publique du Québec
Institute for Work & Health
IWK Health Centre

John Abbott College
Justice Institute of British Columbia

Keenan Research Centre
King's University College at Western University
Kwantlen Polytechnic University

MacEwan University (Grant MacEwan University)
McGill University
McMaster University
Memorial University of Newfoundland
Métis Nation of Ontario
Mount Royal University
Mount Saint Vincent University
Moyo Health and Community Services

Native Women's Association of Canada
North Island College
North York General Hospital
Northern Ontario School of Medicine
Nova Scotia Health Authority

OCAD University
Ontario Centre of Excellence for Child and Youth Mental Health
Ontario Institute for Cancer Research
Ontario Tech University
Ontario Tech University (University of Ontario Institute of Technology)
Ottawa Heart Institute Research Corporation
Ottawa Hospital Research Institute

Princess Margaret Cancer Centre

Québec à Chicoutimi
Québec à Montréal
Québec à Rimouski
Québec à Trois-Rivières
Queen's University

Royal Alexandra Hospital
Royal Roads University
Ryerson University

TÉLUQ
The University of Calgary
The University of Regina
Thompson Rivers University
Toronto General Research Institute
Trent University
Trillium Health Partners

Vancouver Island University

Western University
Western University (The University of Western Ontario)
Wilfrid Laurier University
Women's College Hospital

York University
Yukon University

Back to main page

Displaying 111 through 120 of 150 results (Download Results)

Show results per page

Covid-19 et infodémie : pratiques informationnelles de groupes en situation de vulnérabilité à la COVID -19 au Québec en contexte de pandémie.

Vivion, Maryline | Institut national de santé publique du Québec | Project Grant | $153,000

CIHR Quebec 2021

COVID-19 Variant Supplement – Innovative therapeutic approaches for the 2019-novel coronavirus

Boivin, Guy | CHU de Québec | Operating Grant | $50,000

CIHR Quebec 2021

Covid-19 effects on ARTErial StIffness and vascular AgiNg (CARTESIAN) study- Canada

Agharazii, Mohsen | Université Laval | Operating Grant | $347,260

CIHR Quebec 2021

Evaluation of a digital, rapid self-sampling strategy for individuals with suspected COVID‑19 infection in South Africa and India

Pai, Nitika | McGill University | Project Grant | $378,675

CIHR Quebec 2021

Brain Injury Pandemic Preparedness: Optimizing Community Strategies

Bottari, Carolina | CIUSSS du Centre-Sud-de-l'Île-de-Montréal | Project Grant | $218,025

CIHR Quebec 2021

The Impact of the COVID‑19 pandemic on youth substance use problems and services: Knowledge synthesis with Indigenous Nations and organizations

Wendt, Dennis C | McGill University | Other | $100,000

CIHR Quebec 2021

Évaluation de l’efficacité des probiotiques sur les affections post-COVID-19.

Pasquier, Jean Charles | Université de Sherbrooke | Operating Grant | $997,273

CIHR Quebec 2021

The association between COVID-19-related attitudes, concerns and behaviours in relation to public health policies: A behavioural science approach to optimising policy strategies to improve health, economic and quality of life outcomes (the iCARE Study).

Lavoie, Kim | Université du Québec à Montréal | Project Grant | $638,775

CIHR Quebec 2021

COVID-19 Variant Supplement – Characterization of Covid-19 infection in rheumatoid arthritis patients- the CoViD-in-RA project

Roux, Sophie | Université de Sherbrooke | Operating Grant | $50,000

CIHR Quebec 2021

COVID-19 Variant Supplement – Development of COVID-2019 main protease inhibitors as potential antivirals against the 2019 coronavirus.

Moitessier, Nicolas R | McGill University | Operating Grant | $50,000

CIHR Quebec 2021

The Canadian COVID‑19 Funded Research Database

Advanced Keyword Search

Provinces & Territories (12)

Institutions (175)

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

Y

Years (4)

Funding Agencies (3)

Languages (2)

Funding Amount

Covid-19 et infodémie : pratiques informationnelles de groupes en situation de vulnérabilité à la COVID -19 au Québec en contexte de pandémie.

COVID-19 Variant Supplement – Innovative therapeutic approaches for the 2019-novel coronavirus

Covid-19 effects on ARTErial StIffness and vascular AgiNg (CARTESIAN) study- Canada

Evaluation of a digital, rapid self-sampling strategy for individuals with suspected COVID‑19 infection in South Africa and India

Brain Injury Pandemic Preparedness: Optimizing Community Strategies

The Impact of the COVID‑19 pandemic on youth substance use problems and services: Knowledge synthesis with Indigenous Nations and organizations

Évaluation de l’efficacité des probiotiques sur les affections post-COVID-19.

The association between COVID-19-related attitudes, concerns and behaviours in relation to public health policies: A behavioural science approach to optimising policy strategies to improve health, economic and quality of life outcomes (the iCARE Study).

COVID-19 Variant Supplement – Characterization of Covid-19 infection in rheumatoid arthritis patients- the CoViD-in-RA project

COVID-19 Variant Supplement – Development of COVID-2019 main protease inhibitors as potential antivirals against the 2019 coronavirus.